Targeting Human IL-2 Receptors for Diagnosis and Therapy
Copyright policy )Targeting Human IL-2 Receptors for Diagnosis and Therapy
The high-affinity interleukin-2 receptor (IL-2R) is a multichain receptor with at least three IL-2 binding chains: IL-2R alpha (55 kDa) bound by the monoclonal antibody anti-Tac, IL-2R beta (75 kDa) and Il-2R gamma (64 kDa). The IL-2R alpha also exists as a naturally occurring soluble molecule (sIL-2R alpha). We target the IL-2R for immune intervention since resting normal cells do not express the high-affinity IL-2R, whereas this receptor is on some cells in certain lymphoid neoplasias, select autoimmune disorders, and in individuals rejecting organ allografts. Treatments have included unmodified murine anti-Tac and radioisotopes conjugated to murine anti-Tac. Our emerging understanding of the IL-2R system continues to open possibilities for more specific immune intervention.
- National Cancer Institute United States
- National Institute of Health Pakistan
- National Institutes of Health United States
Mice, Diagnosis, Animals, Antibodies, Monoclonal, Humans, Receptors, Interleukin-2, Immunotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Mice, Diagnosis, Animals, Antibodies, Monoclonal, Humans, Receptors, Interleukin-2, Immunotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).5 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!